Why Evolution Mining, Lynas, ResMed, and Steadfast shares are falling today

These shares are starting the week in the red. But why?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Evolution Mining shares fall over 2.5% as a declining gold price affects the sector, impacting the ASX All Ordinaries Gold index.
  • Lynas Rare Earths drops 6%, likely due to pressures from US-China trade developments affecting rare earths shares.
  • ResMed's shares decrease by 4% following a poor performance of its NYSE-listed shares, despite a buy rating from Ord Minnett predicting a 29% upside.

The S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a decline. In afternoon trade, the benchmark index is down slightly to 8,877.1 points.

Four ASX shares that are falling more than most today are listed below. Here's why they are dropping:

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.

Image source: Getty Images

Evolution Mining Ltd (ASX: EVN)

The Evolution Mining share price is down over 2.5% to $10.57. Investors have been selling this gold miner's shares today after the price of gold pulled back. It isn't just Evolution Mining shares that are falling. This has led to the S&P/ASX All Ordinaries Gold index tumbling by 1.6% at the time of writing.

Lynas Rare Earths Ltd (ASX: LYC)

The Lynas Rare Earths share price is down 6% to $14.33. This is despite there being no news out of the rare earths producer on Monday. However, it is worth noting that a number of rare earths shares have been under pressure since the US and China made progress on trade talks and rare earths export controls.

Resmed Inc. (ASX: RMD)

The Resmed share price is down 4% to $37.86. This follows a poor night of trade for the sleep disorder treatment company's NYSE listed shares on Friday, which has reversed its post-results gains. One broker that is likely to see this as a buying opportunity is Ord Minnett. This morning, the broker retained its buy rating and $48.80 price target on the company's shares. This implies potential upside of 29% for investors over the next 12 months. Ord Minnett was impressed with ResMed's strong performance during the first quarter and has lifted its earnings estimates for FY 2026 and FY 2027. It expects double digit earnings growth each year.

Steadfast Group Ltd (ASX: SDF)

The Steadfast share price is down almost 6% to $5.28. This may have been driven by another note out of Ord Minnett. According to the note, the broker has downgraded this insurance broker network operator's shares to a hold rating with a trimmed price target of $5.80. This follows the release of a disappointing trading update and the temporary standing down of its CEO, Robert Kelly, due to an investigation into a workplace complaint made against him. It said: "Mr Kelly AM will remain on full pay for the duration of the investigation. Given that the investigation into the allegations against Mr Kelly AM is ongoing, and that to date no allegations against him have been substantiated, it would not be appropriate to comment further at this time. The Board will provide further details to the market once this investigation is completed."

Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed and Steadfast Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Lynas Rare Earths Ltd. The Motley Fool Australia has positions in and has recommended ResMed and Steadfast Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A man sitting at his desktop computer leans forward onto his elbows and yawns while he rubs his eyes as though he is very tired.
Share Fallers

Why did DroneShield shares crash 30% in July to new one-year lows?

DroneShield shares got smashed in July. But why.

Read more »

Man with his head on his head with a red declining arrow and A worried man holds his head and look at his computer as the Megaport share price crashes today
Share Fallers

Down 43%! What on earth happened with Liontown shares in July?

Investors pummelled Liontown shares in July. Time to buy?

Read more »

A bored woman looking at her computer, it's bad news.
Share Fallers

These were the worst-performing ASX 200 shares in July

These shares had a tough time in July. Let's find out why.

Read more »

A man dressed in a business suit freefalls from a rocky cliff with a grey sky background.
Share Fallers

Why these 3 ASX 200 stocks are crashing in this week's surging market

Investors sent these three ASX 200 shares tumbling 15% to 18% in this week’s rising market. But why?

Read more »

A man holds his head in his hands after seeing bad news on his laptop screen.
Share Fallers

3 ASX shares down at least 50% in FY26

Let's see why these shares were sold off during the last financial year.

Read more »

Side-on view of a devastated male investor laying his head on his laptop keyboard
ASX Share Market News

5 biggest losers on the ASX 200 in FY26

The worst performers include 2 sector leaders, and all 5 stocks more than halved in value.

Read more »

A man dressed in a business suit freefalls from a rocky cliff with a grey sky background.
Share Fallers

Why DroneShield, WiseTech and Judo shares are leading the ASX 200 lower this week

WiseTech, DroneShield, and Judo shareholders have had a week to forget. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Judo Capital, Minerals 260, Santos, and Worley shares are dropping today

These shares are under pressure on Thursday. What's going on?

Read more »